Women's health · Live ClinicalTrials.gov data

Fezolinetant (Veozah) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 fezolinetant (Veozah) trials on ClinicalTrials.gov by enrolment, 1 of them actively recruiting. The next phase 3 primary completion among them is expected Mar 2028. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

11

Phase 3 trials

1

Actively recruiting

Mar 2028

Next phase 3 primary completion

6,706

Participants across trials

Astellas Pharma Global Development, Inc.

Lead sponsor by trial count

fezolinetant (16)5 active2017–2031
fezolinetant
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompleted
'17
'19
'21
'23
'25
'27
'29
'31
fezolinetant
A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)P2
Skylight 4P3
Skylight 2P3
Skylight 1P3
Moonlight 1P3
Moonlight 3P3
DaylightP3
StarlightP2
Starlight 2P3
Starlight 3P3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyP3
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through MenopauseP2
Focusing on the Menopausal Transition to Improve Mid-Life Women's HealthP2
FAVES-BP3
A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through MenopauseP3
HERBRAVEHEARTP4

Upcoming readouts

4 ahead · fezolinetant

Select a trial to load its full ClinicalTrials.gov record.

Key fezolinetant trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT07732452HERBRAVEHEART: Hormone thERapy Effects on BRAin-HEART Health During the Menopausal TransitionPhase 4Not yet recruitingNov 2028
NCT06440967A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are …Phase 3Active, not recruitingJun 2026
NCT07829653A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Men…Phase 3Not yet recruitingMar 2028
NCT07606664FAVES-B: Fezolinetant and Vascular Health and Brain HealthPhase 3Not yet recruitingNov 2029
NCT04003142Skylight 2: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going T…Phase 3CompletedJul 2020
NCT04003155Skylight 1: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going T…Phase 3CompletedOct 2020
NCT04003389Skylight 4: A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes …Phase 3CompletedJan 2022
NCT04234204Moonlight 1: A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia…Phase 3CompletedApr 2022
NCT04451226Moonlight 3: A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Rel…Phase 3CompletedJun 2022
NCT05033886Daylight: A Study of Fezolinetant to Treat Hot Flashes in Women Going Through MenopausePhase 3CompletedMar 2023
NCT06206408Starlight 2: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Meno…Phase 3CompletedOct 2025
NCT06206421Starlight 3: A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopau…Phase 3CompletedMar 2026

Track fezolinetant with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track fezolinetant

FAQ

How many clinical trials are running for fezolinetant?
ClinicalTrials.gov lists more than 16 phase 2–4 fezolinetant trials. This page tracks the 16 largest by enrolment: 4 phase 2, 11 phase 3, and 1 phase 4 among them, with 1 actively recruiting. Updated daily.
Are there clinical trials for Veozah?
Veozah is the brand name for fezolinetant, so fezolinetant trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 fezolinetant trials. This page tracks the 16 largest by enrolment: 4 phase 2, 11 phase 3, and 1 phase 4 among them, with 1 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare fezolinetant against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.

Keep following
what matters.

Choose the drugs, companies or disease areas you follow. Bring trial changes and upcoming readouts into one watch.

Build your watch

Choose what to track in the watch builder.